About Harmosan Pharma
Harmosan Pharma was founded in 1968 in Frankfurt Am Main, Germany, and operates within the energy sector. Electricity generation is conducted alongside the management of a gas drying plant. Services encompass energy production processes, including customer inquiry handling and adherence to regulatory standards. Operations focus on these core activities to support regional energy needs.
- Headquarter Frankfurt Am Main, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Harmosan Pharma
Detailed funding history for Harmosan Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Harmosan Pharma
Harmosan Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Lupin.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical products including generics, biosimilars, and APIs are manufactured.
|
Locked | Locked | Locked |
Investor details for Harmosan Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Harmosan Pharma
Investment portfolio details for Harmosan Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Harmosan Pharma
Detailed financials for Harmosan Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Harmosan Pharma Comparisons
Peer comparison for Harmosan Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Harmosan Pharma
Detailed competitors of Harmosan Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Harmosan Pharma
Complete news archive for Harmosan Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harmosan Pharma
Harmosan Pharma was founded in 1968.
Harmosan Pharma is headquartered in Frankfurt Am Main, Germany. It is registered at Frankfurt Am Main, Hesse, Germany.
Werner Schneider is the current CEO of Harmosan Pharma.
Harmosan Pharma was founded in 1968 in Frankfurt Am Main, Germany, and operates within the energy sector. Electricity generation is conducted alongside the management of a gas drying plant. Services encompass energy production processes, including customer inquiry handling and adherence to regulatory standards. Operations focus on these core activities to support regional energy needs.
Harmosan Pharma has 1 investor. Key investors include Lupin.